Atlas Trials

Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme

Clinical trial NCT02017249 · COMPLETED

Trial details

NCT number
NCT02017249
Sponsor
Inova Health Care Services
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Glioblastoma Multiforme
Start date
2014-03-01
Primary completion
2015-09-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.